Sign inJoin waitlistJoin the waitlist

NB

Naveen Basappa

Credentials: ·

History

Residency
2009–2012
Medical School
2005–2009

Research

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised,…
The Lancet Oncology · 2023 · 140 citations
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Cancer · 2018 · 62 citations
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell…
European Urology · 2023 · 59 citations

DH
Daniel Heng
62 papers
AL
Aly-Khan Lalani
40 papers · 8 as a resident
RB
Rodney Breau
40 papers
BB
Bimal Bhindi
27 papers
Toni Choueiri
15 papers
GG
Geoffrey Gotto
12 papers
DB
Dominick Bosse
10 papers
JN
Jasmir Nayak
9 papers
Sumanta Pal
9 papers
Rana McKay
8 papers · 3 as a resident
Christopher Wallis
6 papers · 5 as a fellow
HC
Henry Conter
5 papers · 1 as a fellow